Jubin W Ryu, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ryu’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A118428 · Current
Licensed to practise in California · since 2011 · expires 2027-09-30 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$382,558
Medicare paid this office $382,558 for 880 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 488 | $80,125 | $105 |
| Short return visit (20+ min) | 598 | $69,175 | $75 |
| Destruction of precancer skin growth, 15 or more growths | 184 | $50,117 | $162 |
| Destruction of precancer skin growth, 1 growth | 542 | $46,022 | $54 |
| Destruction of skin growth, 1-14 growths | 231 | $31,494 | $109 |
See all 15 services
| Return visit (30+ min) | 488 | $80,125 | $105 |
| Short return visit (20+ min) | 598 | $69,175 | $75 |
| Destruction of precancer skin growth, 15 or more growths | 184 | $50,117 | $162 |
| Destruction of precancer skin growth, 1 growth | 542 | $46,022 | $54 |
| Destruction of skin growth, 1-14 growths | 231 | $31,494 | $109 |
| Destruction of precancer skin growth, 2-14 growths | 483 | $27,089 | $7 |
| Biopsy of related skin growth, first growth | 230 | $24,441 | $89 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,506 | $300 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 15 | $3,127 | $101 |
| Punch biopsy, first skin growth | 20 | $2,770 | $126 |
| New patient visit (45+ min) | 19 | $2,709 | $143 |
| Application of light to destroy precancer skin growth | 15 | $2,456 | $123 |
| Biopsy of related skin growth, each additional growth | 31 | $2,039 | $50 |
| New patient visit (30+ min) | 22 | $1,297 | $59 |
| Injection into skin growth, 1-7 growths | 11 | $973 | $49 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 14 | More than 69% of doctors who do this |
| Removal of skin lesions | 2464 | More than 98% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 276 | More than 89% of doctors who do this |
Who their Medicare patients are
880 Original Medicare patients in 2024. Average age 78 · Under 65 1% · 85 and older 21% · Women 32% · Also on Medicaid 3% · Health risk score 0.89. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 54% · Coronary heart disease 23% · Atrial fibrillation 19% · Cancer 17% · Chronic kidney disease 15% · Diabetes 12% · Depression 9% · Heart failure 8% · COPD 6% · Dementia 5% · Stroke 5%.
The office billed $1,409,073, Medicare allowed $536,344 and paid $382,558; for 7,888 services of 49 kinds; $561 of it was for drugs given in the office and $381,997 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 880 | 7,888 | 78 | 0.89 | $1,409,073 | $382,558 |
| 2023 | 822 | 8,547 | 77 | 0.87 | $1,215,374 | $354,255 |
| 2022 | 847 | 8,641 | 78 | 0.85 | $1,163,443 | $349,374 |
| 2021 | 762 | 7,264 | 77 | 0.85 | $1,079,268 | $333,335 |
| 2020 | 768 | 4,856 | 77 | 0.85 | $789,400 | $221,264 |
| 2019 | 699 | 3,819 | 77 | 0.90 | $686,878 | $189,672 |
| 2018 | 663 | 4,091 | 77 | 0.88 | $671,525 | $181,452 |
| 2017 | 642 | 4,256 | 76 | 0.93 | $568,053 | $159,339 |
| 2016 | 461 | 2,319 | 76 | 0.89 | $411,967 | $127,661 |
| 2015 | 233 | 696 | 73 | 0.90 | $154,638 | $41,926 |
| 2014 | 37 | 104 | 70 | 1.13 | $28,706 | $2,973 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 465 | $83,176 | $106 |
| Short return visit (20+ min) | 548 | $60,873 | $73 |
| Destruction of precancer skin growth, 1 growth | 562 | $50,157 | $51 |
| Destruction of precancer skin growth, 2-14 growths | 484 | $33,898 | $7 |
| Biopsy of related skin growth, first growth | 258 | $31,433 | $97 |
| Destruction of skin growth, 1-14 growths | 184 | $27,121 | $113 |
| Destruction of precancer skin growth, 15 or more growths | 93 | $23,121 | $173 |
| New patient visit (45+ min) | 40 | $5,614 | $140 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 22 | $4,526 | $126 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $4,168 | $321 |
| Biopsy of related skin growth, each additional growth | 41 | $2,478 | $52 |
| Punch biopsy, first skin growth | 17 | $2,388 | $126 |
| Application of light to destroy precancer skin growth | 11 | $2,238 | $160 |
| New patient visit (30+ min) | 24 | $1,913 | $80 |
| Destruction of skin growth, 15 or more growths | 11 | $1,500 | $115 |
| Injection into skin growth, 1-7 growths | 11 | $952 | $50 |
2022: 15 services
| Short return visit (20+ min) | 657 | $83,637 | $74 |
| Return visit (30+ min) | 374 | $57,083 | $109 |
| Destruction of precancer skin growth, 1 growth | 557 | $50,258 | $50 |
| Destruction of precancer skin growth, 2-14 growths | 490 | $33,131 | $7 |
| Biopsy of related skin growth, first growth | 254 | $32,325 | $100 |
| Destruction of skin growth, 1-14 growths | 194 | $28,286 | $110 |
| Destruction of precancer skin growth, 15 or more growths | 58 | $14,050 | $176 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 21 | $7,238 | None |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 27 | $5,199 | $127 |
| Application of light to destroy precancer skin growth | 22 | $3,331 | $151 |
| Biopsy of related skin growth, each additional growth | 42 | $3,251 | $54 |
| New patient visit (45+ min) | 21 | $2,769 | $132 |
| New patient visit (30+ min) | 25 | $2,066 | $83 |
| Punch biopsy, first skin growth | 15 | $2,050 | $137 |
| Short return visit | 29 | $1,421 | $49 |
2021: 14 services
| Short return visit (20+ min) | 597 | $76,904 | $78 |
| Return visit (30+ min) | 358 | $52,149 | $105 |
| Destruction of precancer skin growth, 1 growth | 490 | $48,283 | $53 |
| Destruction of precancer skin growth, 2-14 growths | 422 | $26,423 | $7 |
| Destruction of skin growth, 1-14 growths | 174 | $25,699 | $115 |
| Biopsy of related skin growth, first growth | 211 | $25,663 | $101 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 21 | $8,808 | None |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 21 | $4,066 | $136 |
| Application of light to destroy precancer skin growth | 21 | $3,474 | $158 |
| Biopsy of related skin growth, each additional growth | 35 | $2,856 | $55 |
| New patient visit (45+ min) | 21 | $2,639 | $126 |
| New patient visit (30+ min) | 22 | $2,314 | $105 |
| Punch biopsy, first skin growth | 13 | $1,708 | $131 |
| Short return visit | 21 | $1,078 | $49 |
2020: 13 services
| Short return visit (20+ min) | 496 | $43,161 | $60 |
| Return visit (30+ min) | 340 | $38,625 | $89 |
| Destruction of precancer skin growth, 1 growth | 430 | $31,929 | $50 |
| Destruction of skin growth, 1-14 growths | 161 | $20,493 | $107 |
| Biopsy of related skin growth, first growth | 187 | $20,180 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 346 | $12,898 | $6 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 13 | $4,736 | None |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $3,883 | $299 |
| New patient visit (30+ min) | 48 | $3,835 | $80 |
| Biopsy of related skin growth, each additional growth | 37 | $3,130 | $55 |
| Punch biopsy, first skin growth | 21 | $2,888 | $131 |
| Application of light to destroy precancer skin growth | 13 | $2,231 | $149 |
| Short return visit | 51 | $2,111 | $39 |
2019: 12 services
| Short return visit (20+ min) | 495 | $52,010 | $63 |
| Return visit (30+ min) | 242 | $28,601 | $95 |
| Destruction of precancer skin growth, 1 growth | 304 | $24,323 | $50 |
| Biopsy of related skin growth, first growth | 206 | $22,814 | $88 |
| Destruction of skin growth, 1-14 growths | 143 | $18,622 | $108 |
| Destruction of precancer skin growth, 2-14 growths | 229 | $7,335 | $5 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $4,763 | $298 |
| New patient visit (30+ min) | 52 | $4,715 | $91 |
| Short return visit | 61 | $2,875 | $39 |
| Punch biopsy, first skin growth | 16 | $2,170 | $128 |
| Biopsy of related skin growth, each additional growth | 28 | $1,798 | $54 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,364 | $124 |
2018: 11 services
| Short return visit (20+ min) | 478 | $47,734 | $59 |
| Destruction of precancer skin growth, 1 growth | 305 | $26,771 | $50 |
| Biopsy of single growth of skin and/or tissue | 219 | $26,697 | $97 |
| Return visit (30+ min) | 203 | $21,475 | $86 |
| Destruction of skin growth, 1-14 growths | 97 | $11,976 | $101 |
| Destruction of precancer skin growth, 2-14 growths | 254 | $8,593 | $5 |
| New patient visit (30+ min) | 76 | $6,240 | $82 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,052 | $289 |
| Short return visit | 78 | $3,560 | $39 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 16 | $2,357 | $131 |
| Biopsy of each additional growth of skin and/or tissue | 17 | $523 | $31 |
2017: 11 services
| Short return visit (20+ min) | 453 | $44,406 | $59 |
| Destruction of precancer skin growth, 1 growth | 319 | $25,970 | $52 |
| Biopsy of single growth of skin and/or tissue | 195 | $22,954 | $95 |
| Return visit (30+ min) | 141 | $14,947 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 266 | $11,673 | $5 |
| Destruction of skin growth, 1-14 growths | 88 | $10,865 | $104 |
| New patient visit (30+ min) | 119 | $9,810 | $82 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 17 | $5,370 | $298 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 16 | $2,028 | $127 |
| Short return visit | 44 | $1,895 | $39 |
| Biopsy of each additional growth of skin and/or tissue | 34 | $1,312 | $31 |
2016: 9 services
| Short return visit (20+ min) | 338 | $30,034 | $64 |
| Destruction of precancer skin growth, 1 growth | 176 | $11,437 | $53 |
| Biopsy of single growth of skin and/or tissue | 104 | $10,311 | $96 |
| Destruction of skin growth, 1-14 growths | 71 | $9,856 | $106 |
| New patient visit (30+ min) | 110 | $8,837 | $80 |
| Return visit (30+ min) | 54 | $5,142 | $84 |
| Destruction of precancer skin growth, 2-14 growths | 151 | $4,308 | $5 |
| Short return visit | 44 | $2,168 | $41 |
| Biopsy of each additional growth of skin and/or tissue | 16 | $513 | $30 |
2015: 13 services
| New patient visit (30+ min) | 70 | $7,102 | $101 |
| Short return visit (20+ min) | 77 | $6,297 | $68 |
| Return visit (30+ min) | 39 | $4,348 | $104 |
| Destruction of skin growth, 1-14 growths | 33 | $4,089 | $117 |
| Biopsy of single growth of skin and/or tissue | 40 | $4,067 | $99 |
| Destruction of precancer skin growth, 1 growth | 39 | $2,008 | $49 |
| New patient visit (15+ min) | 28 | $1,836 | $66 |
| Destruction of precancer skin growth, 2-14 growths | 33 | $909 | $6 |
| Short return visit (20+ min) | 22 | $868 | $35 |
| Destruction of skin growth, 1-14 growths | 11 | $835 | $64 |
| Short return visit | 18 | $799 | $44 |
| New patient visit (15+ min) | 12 | $433 | $36 |
| Short return visit | 11 | $214 | $19 |
2014: 2 services
| New patient visit (15+ min) | 15 | $635 | $42 |
| Short return visit (20+ min) | 13 | $608 | $43 |
Drugs they prescribed that Part D paid
$214,977
Pharmacies billed $214,977 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 955) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
894 generic and 61 brand-name prescriptions · $214,977 in drug cost · 43 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 27 | $124,340 | $4,605 |
| Fluorouracil | 117 | $8,184 | $70 |
| Clobetasol Propionate | 58 | $4,572 | $79 |
| Calcipotriene | 14 | $2,955 | $211 |
| Ketoconazole | 74 | $1,660 | $22 |
See all 23 drugs
| Dupixent | 27 | $124,340 | $4,605 |
| Fluorouracil | 117 | $8,184 | $70 |
| Clobetasol Propionate | 58 | $4,572 | $79 |
| Calcipotriene | 14 | $2,955 | $211 |
| Ketoconazole | 74 | $1,660 | $22 |
| Doxycycline Hyclate | 49 | $1,405 | $29 |
| Tacrolimus | 12 | $1,386 | $116 |
| Betamethasone Diprop Augmented | 25 | $1,319 | $53 |
| Triamcinolone Acetonide | 104 | $1,160 | $11 |
| Desonide | 17 | $1,089 | $64 |
| Fluocinonide | 34 | $1,001 | $29 |
| Metronidazole | 13 | $806 | $62 |
| Clindamycin Phosphate | 28 | $803 | $29 |
| Clotrimazole-Betamethasone | 22 | $690 | $31 |
| Ciclopirox | 14 | $689 | $49 |
| Mupirocin | 72 | $593 | $8 |
| Nystatin | 45 | $579 | $13 |
| Azelaic Acid | 13 | $533 | $41 |
| Mometasone Furoate | 22 | $454 | $21 |
| Valacyclovir | 29 | $337 | $12 |
| Ciclopirox | 15 | $246 | $16 |
| Hydrocortisone | 15 | $79 | $5 |
| Prednisone | 13 | $50 | $4 |
Year by year
| 2024 | 955 | 411 | 0% (0) | 6% | $214,977 |
| 2023 | 1,034 | 426 | 0% (0) | None | $183,792 |
| 2022 | 875 | 389 | 0% (0) | 6% | $100,803 |
| 2021 | 848 | 353 | 0% (0) | 6% | $79,190 |
| 2020 | 708 | 308 | 0% (0) | 11% | $55,676 |
| 2019 | 629 | 310 | 0% (0) | 9% | $31,812 |
| 2018 | 569 | 262 | 0% (0) | 5% | $36,298 |
| 2017 | 506 | 247 | 0% (0) | None | $60,513 |
| 2016 | 359 | 185 | 0% (0) | 11% | $40,805 |
| 2015 | 187 | 94 | None | 6% | $19,293 |
| 2014 | 40 | 23 | 0% (0) | None | $4,566 |
| 2013 | 76 | 20 | None | None | $7,259 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Dupixent | 32 | $123,227 | $3,851 |
| Fluorouracil | 145 | $11,582 | $80 |
| Tacrolimus | 22 | $6,930 | $315 |
| Calcipotriene | 26 | $5,994 | $231 |
| Clobetasol Propionate | 66 | $3,699 | $56 |
| Fluocinonide | 52 | $2,777 | $53 |
| Ketoconazole | 78 | $2,415 | $31 |
| Metronidazole | 22 | $1,837 | $84 |
| Azelaic Acid | 11 | $1,789 | $163 |
| Mupirocin | 97 | $1,324 | $14 |
| Triamcinolone Acetonide | 115 | $1,317 | $11 |
| Doxycycline Hyclate | 40 | $1,305 | $33 |
| Betamethasone Diprop Augmented | 19 | $955 | $50 |
| Ciclopirox | 15 | $909 | $61 |
| Econazole Nitrate | 13 | $764 | $59 |
| Clotrimazole-Betamethasone | 15 | $715 | $48 |
| Mometasone Furoate | 27 | $687 | $25 |
| Valacyclovir | 21 | $681 | $32 |
| Hydroxychloroquine Sulfate | 15 | $656 | $44 |
| Clindamycin Phosphate | 17 | $559 | $33 |
| Nystatin | 36 | $512 | $14 |
| Betamethasone Dipropionate | 15 | $453 | $30 |
| Prednisone | 18 | $122 | $7 |
| Hydrocortisone | 14 | $95 | $7 |
| Cephalexin | 12 | $67 | $6 |
2022: 18 drugs
| Dupixent | 15 | $53,827 | $3,588 |
| Fluorouracil | 110 | $11,067 | $101 |
| Clobetasol Propionate | 93 | $5,813 | $63 |
| Calcipotriene | 25 | $5,494 | $220 |
| Tacrolimus | 17 | $4,137 | $243 |
| Fluocinonide | 42 | $1,970 | $47 |
| Metronidazole | 23 | $1,751 | $76 |
| Betamethasone Diprop Augmented | 19 | $1,708 | $90 |
| Triamcinolone Acetonide | 129 | $1,498 | $12 |
| Ketoconazole | 40 | $1,321 | $33 |
| Mupirocin | 117 | $1,254 | $11 |
| Desonide | 15 | $1,111 | $74 |
| Clindamycin Phosphate | 19 | $972 | $51 |
| Doxycycline Hyclate | 25 | $806 | $32 |
| Nystatin | 36 | $623 | $17 |
| Hydroxychloroquine Sulfate | 11 | $285 | $26 |
| Valacyclovir | 11 | $161 | $15 |
| Hydrocortisone | 16 | $130 | $8 |
2021: 18 drugs
| Dupixent | 11 | $37,536 | $3,412 |
| Fluorouracil | 102 | $8,995 | $88 |
| Clobetasol Propionate | 85 | $4,118 | $48 |
| Econazole Nitrate | 26 | $2,702 | $104 |
| Clindamycin Phosphate | 29 | $2,532 | $87 |
| Fluocinonide | 40 | $2,043 | $51 |
| Desonide | 23 | $1,658 | $72 |
| Metronidazole | 17 | $1,620 | $95 |
| Triamcinolone Acetonide | 122 | $1,447 | $12 |
| Azelaic Acid | 12 | $1,259 | $105 |
| Ketoconazole | 36 | $1,162 | $32 |
| Mupirocin | 105 | $1,032 | $10 |
| Nystatin | 28 | $493 | $18 |
| Doxycycline Hyclate | 14 | $481 | $34 |
| Hydroxychloroquine Sulfate | 11 | $261 | $24 |
| Valacyclovir | 18 | $191 | $11 |
| Hydrocortisone | 20 | $115 | $6 |
| Prednisone | 13 | $76 | $6 |
2020: 16 drugs
| Fluorouracil | 71 | $8,398 | $118 |
| Clobetasol Propionate | 54 | $4,118 | $76 |
| Fluocinonide | 54 | $3,283 | $61 |
| Tretinoin | 14 | $2,607 | $186 |
| Clindamycin Phosphate | 24 | $2,348 | $98 |
| Triamcinolone Acetonide | 129 | $1,773 | $14 |
| Econazole Nitrate | 19 | $1,288 | $68 |
| Desonide | 13 | $1,221 | $94 |
| Metronidazole | 12 | $1,064 | $89 |
| Mupirocin | 105 | $1,009 | $10 |
| Betamethasone Dipropionate | 16 | $856 | $53 |
| Mometasone Furoate | 21 | $710 | $34 |
| Ketoconazole | 19 | $551 | $29 |
| Nystatin | 18 | $496 | $28 |
| Prednisone | 16 | $105 | $7 |
| Hydrocortisone | 11 | $90 | $8 |
2019: 13 drugs
| Fluorouracil | 63 | $6,763 | $107 |
| Fluocinonide | 49 | $3,030 | $62 |
| Clobetasol Propionate | 30 | $2,904 | $97 |
| Triamcinolone Acetonide | 118 | $1,692 | $14 |
| Econazole Nitrate | 25 | $1,483 | $59 |
| Clindamycin Phosphate | 18 | $1,444 | $80 |
| Betamethasone Dipropionate | 20 | $1,036 | $52 |
| Desonide | 12 | $879 | $73 |
| Mometasone Furoate | 33 | $850 | $26 |
| Mupirocin | 78 | $745 | $10 |
| Ketoconazole | 18 | $687 | $38 |
| Nystatin | 15 | $331 | $22 |
| Valacyclovir | 14 | $225 | $16 |
2018: 16 drugs
| Fluorouracil | 26 | $3,128 | $120 |
| Fluocinonide | 44 | $3,016 | $69 |
| Clobetasol Propionate | 24 | $2,259 | $94 |
| Econazole Nitrate | 19 | $1,677 | $88 |
| Triamcinolone Acetonide | 100 | $1,659 | $17 |
| Clindamycin Phosphate | 23 | $1,567 | $68 |
| Betamethasone Diprop Augmented | 20 | $1,511 | $76 |
| Metronidazole | 11 | $1,067 | $97 |
| Mometasone Furoate | 26 | $767 | $30 |
| Mupirocin | 64 | $703 | $11 |
| Doxycycline Hyclate | 24 | $422 | $18 |
| Nystatin | 20 | $373 | $19 |
| Ciclopirox | 11 | $298 | $27 |
| Spironolactone | 17 | $197 | $12 |
| Hydrocortisone | 16 | $132 | $8 |
| Hydroxyzine | 11 | $102 | $9 |
2017: 16 drugs
| Fluocinonide | 51 | $3,504 | $69 |
| Ciclopirox | 17 | $2,866 | $169 |
| Econazole Nitrate | 19 | $2,493 | $131 |
| Clobetasol Propionate | 16 | $1,725 | $108 |
| Fluorouracil | 11 | $1,300 | $118 |
| Triamcinolone Acetonide | 98 | $1,244 | $13 |
| Clindamycin Phosphate | 16 | $1,234 | $77 |
| Doxycycline Hyclate | 13 | $970 | $75 |
| Sulfacetamide | 11 | $893 | $81 |
| Mometasone Furoate | 25 | $780 | $31 |
| Betamethasone Dipropionate | 15 | $636 | $42 |
| Mupirocin | 42 | $351 | $8 |
| Ciclopirox | 13 | $326 | $25 |
| Spironolactone | 14 | $104 | $7 |
| Valacyclovir | 11 | $83 | $8 |
| Hydrocortisone | 13 | $61 | $5 |
2016: 7 drugs
| Fluocinonide | 37 | $3,417 | $92 |
| Clobetasol Propionate | 17 | $2,834 | $167 |
| Triamcinolone Acetonide | 87 | $1,518 | $17 |
| Sulfacetamide | 11 | $1,129 | $103 |
| Mometasone Furoate | 18 | $473 | $26 |
| Valacyclovir | 11 | $265 | $24 |
| Mupirocin | 28 | $244 | $9 |
2015: 6 drugs
| Econazole Nitrate | 13 | $3,005 | $231 |
| Fluocinonide | 27 | $2,873 | $106 |
| Clobetasol Propionate | 16 | $2,747 | $172 |
| Desonide | 12 | $1,794 | $149 |
| Triamcinolone Acetonide | 46 | $714 | $16 |
| Mupirocin | 13 | $106 | $8 |
2013: 1 drug
| Prednisone | 17 | $81 | $5 |
Money from drug and device companies
$87 in 2025
| 2025 | 3 | 4 | None | $87 |
| 2024 | 2 | 2 | None | $53 |
| 2023 | 1 | 1 | None | $15 |
| 2021 | 1 | 1 | None | $26 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $36 | 2 payments
|
| Ucb | Bimzelx | $30 | 1 payment
|
| Amgen | Otezla | $22 | 1 payment
|
See all 4 published payments
| Amgen | Meals · 2025-12-10 | Otezla | $22 |
| Arcutis Biotherapeutics | Meals · 2025-10-07 | Zoryve | $21 |
| Ucb | Meals · 2025-06-24 | Bimzelx | $30 |
| Arcutis Biotherapeutics | Meals · 2025-02-18 | Zoryve | $14 |
See earlier years (2024, 2023, 2021)
2024: $53
| Novartis Pharmaceuticals | Cosentyx | $28 | 1 payment
|
| Pfizer | Eucrisa | $25 | 1 payment
|
2023: $15
| Pfizer | Cibinqo | $15 | 1 payment
|
2021: $26
| AbbVie | Skyrizi | $26 | 1 payment
|
Professional record
- NPI
- 1992021273
- Licence
- CA A118428California A118428: Current · expires 2027-09-30
- Trained
- Harvard Medical School, 2010
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Student in a training program (390200000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2010-04-12
- NPI last updated
- 2020-05-29
- NPI record certified
- 2020-05-29
This is when the NPI record was last certified, not a medical board exam.